학술논문
Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.
Document Type
Journal
Author
Dimopoulos, Meletios A.; Schjesvold, Fredrik; Doronin, Vadim; Vinogradova, Olga; Quach, Hang; Leleu, Xavier; Yolanda, Gonzalez Montes; Ramasamy, Karthik; Pompa, Alessandra; Levin, Mark-David; Lee, Cindy; Mellqvist, Ulf-Henrik; Fenk, Roland; Sati, Hamdi; Vorog, Alexander; Labotka, Richard J.; Du, Jichang; Darif, Mohamed; Kumar, Shaji
Source
Subject
Language
English
ISSN
15277755